КОРПОРАТИВНЫЙ СИМПОЗИУМ

GMT +3 / CET +1 October 22, Thursday
Dulaglutide as the only once - weekly first injectable option in type 2 diabetes: When and why?
20.05 - 20.10  Opening - Salah Abusnana
20.10 - 20.30 Dulaglutide Clinical Trials and Patient Cases - Iain Cranston
20.30 - 20.35 Q/A Session moderated by - Salah Abusnana
Translation in Russian, Arabic and Turkish will be available • Türkçe tercüme yapılacaktır • Будет обеспечен перевод на русский язык • الترجمة باللغة العربية ستكون مُتاحة
Copyright © Endo Bridge . All Rights Reserved
LookUs & Online Makale